Merck Wins Latest State Court Fosamax Trial

Merck announced this morning that the latest individual state court Fosamax ONJ plaintiff in New Jersey was unable to prove that her jaw problems were primarily a result of the Merck drug.

I am on the road this week, and will return with more fullsome reports next week — including a great tidbit from a loyal reader — on how a recent study found that more Ezetimibe (branded as Merck’s Zetia) is worse than less, for some patients.

Be excellent to one another.


There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: